Showing 2121-2130 of 4166 results for "".
- Phase 3 Study Shows Teprotumumab Significantly Reduced Double Vision for People with Active Thyroid Eye Diseasehttps://modernod.com/news/new-data-from-teprotumumab-phase-3-study-shows-significantly-reduced-double-vision-for-people-with-active-thyroid-eye-disease/2476988/Horizon Therapeutics announced new data from the phase 3 OPTIC confirmatory clinical trial showing that teprotumumab provided significant benefit on several effects of active thyroid eye disease (TED) compared with placebo, including diplopia (double vision), quality of life (QoL) and clinical ac
- LumiThera Announces US LIGHTSITE III Clinical Trial Meets Primary Efficacy Endpoint in Improving Vision in Dry AMD Patientshttps://modernod.com/news/lumithera-announces-us-lightsite-iii-clinical-trial-meets-primary-efficacy-endpoint-in-improving-vision-in-dry-amd-patients/2480712/LumiThera announced positive findings in its LIGHTSITE III multicenter clinical trial in non-neovascular (dry) age-related macular degeneration (AMD) subjects treated with the Valeda Light Delivery System. LIGHTSITE III, a prospective, double-masked, randomized, multicenter clinica
- Johnson & Johnson Vision Showcases 30 New Sets of Scientific Data on Myopia, Refractive Technologies, IOLs and More at ARVOhttps://modernod.com/news/johnson-johnson-vision-showcases-30-new-sets-of-scientific-data-on-myopia-refractive-technologies-iols-and-more-at-arvo/2481554/Johnson & Johnson Vision announced that it is presenting 30 sets of research spanning the spectrum of eye health including myopia, refractive technology, sphere, intraocular lenses, astigmatism, consumer eye health, and vision science at the Association for Research in Vision and Ophthalmolog
- Proof of COVID-19 Vaccination and Face Coverings Will Not Be Required to Attend Vision Expo East, March 31-April 3, 2022https://modernod.com/news/proof-of-covid-19-vaccination-and-face-coverings-will-not-be-required-to-attend-vision-expo-east-march-31-april-3-2022/2480686/The Vision Council and RX, co-organizers of Vision Expo, share that, in accordance with New York State and New York City guidelines and the updated requirements of the Javits Center, proof of COVID-19 vaccination and face coverings will not be required to attend Vision Expo East, tak
- Eyenovia Announces Topline Results From VISION-1 Phase 3 Study of MicroLine for the Treatment of Presbyopiahttps://modernod.com/news/eyenovia-announces-positive-topline-results-from-vision-1-phase-3-clinical-study-of-microline-for-the-treatment-of-presbyopia/2479241/Eyenovia announced that its VISION-1 study evaluating the company’s proprietary pilocarpine formulation, MicroLine, for the temporary improvement of near vision in adults with presbyopia, achieved its primary endpoint. Preparations are underway for a second phase 3 registration study, VISION-2. T
- Johnson & Johnson Vision Presents New Myopia, Cataract, Refractive, and Meibomian Gland Dysfunction Data at ARVO 2021https://modernod.com/news/johnson-johnson-vision-presents-new-myopia-cataract-refractive-and-meibomian-gland-dysfunction-data-at-arvo-2021/2479152/Johnson & Johnson Vision will present nearly 30 posters and papers of research data on myopia, IOL, phacoemulsification, refractive, and meibomian gland dysfunction at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting. This year’s premier vision research meet
- Vision Expo Announces Topic for July 22 Virtual EYE2EYE Series Coffee Talkhttps://modernod.com/news/vision-expo-announces-topic-for-july-22-virtual-eye2eye-series-coffee-talk/2478039/On July 22 at 12:15 pm EDT, The Vision Council and Vision Expo will host “Open Your Eyes! What Allyship of Diversity & Inclusion Looks Like” as part of the Virtual EYE2EYE Series, a weekly series of virtual panels and interactive conversations inspired by Vision Expo’s EYE2EYE edu
- Johnson & Johnson Vision Appoints Erin McEachren as Regional Vice President, Surgical, EMEAhttps://modernod.com/news/johnson-johnson-vision-appoints-erin-mceachren-as-regional-vice-president-surgical-emea/2477847/Johnson & Johnson Vision has appointed Erin McEachren to the position of Regional Vice President for Johnson & Johnson Surgical Vision, EMEA. In this role, Ms. McEachren will lead Johnson & Johnson’s high-performance surgical vision team to address the unmet needs of patients and eye
- The Vision Council Releases Midpoint March COVID-19 Optical Impact Consumer Study to Membershttps://modernod.com/news/the-vision-council-releases-midpoint-march-covid-19-optical-impact-consumer-study-to-members/2477445/The Vision Council has released the results of the Midpoint March COVID-19 Optical Impact Consumer Study to members. Conducted by The Vision Council’s research team as part of The Vision Council’s monthly VisionWatch survey, the Midpoint March survey builds upon the study launched in February to
- The Vision Council Releases Updated Version of Data Communication Standardhttps://modernod.com/news/the-vision-council-releases-updated-version-of-data-communication-standard/2482899/The Vision Council announced the official release and approval of Version 3.14 of its Data Communication Standard in an effort to advance the efficiency, accuracy, and interoperability of optical manufacturing systems.